Psychosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Psychosis is a mental disorder characterized by a disconnect from reality, evident through a decline in daily functioning and a breakdown of personality manifested as disturbances in emotions, thoughts (like delusions), perceptions (such as hallucinations), and behavior. The primary symptoms of psychosis include:
• Hallucinations: These involve perceiving things that aren’t present, such as hearing, seeing, or even feeling, smelling, or tasting things that have no physical existence. Hearing voices is a common form of hallucination.
• Delusions: These are false beliefs that, upon rational examination, are untrue. Sometimes, the cause of psychosis can be linked to specific mental health disorders, including: – Schizophrenia leads to various psychological symptoms, including hallucinations and delusions.
• Bipolar disorder: A condition affecting mood, characterized by alternating episodes of depression (lows) and mania (highs).
• Severe depression: In some cases, severe depression can also trigger symptoms of psychosis.
Additionally, trauma, stress, physical ailments like Parkinson’s disease or brain tumors, as well as substance abuse (drugs or alcohol) can all act as triggers for psychosis. Nonetheless, a combination of genetic, biological, environmental, and psychological elements is believed to play a role. Managing psychosis involves a combination of approaches, including:
• Antipsychotic medication: These drugs help alleviate the symptoms of psychosis.
• Psychological therapies: Cognitive Behavioral Therapy (CBT), a one-on-one talking therapy, has shown effectiveness in assisting individuals with schizophrenia. Family therapy, where applicable, has been found to reduce the necessity for hospitalization in people with psychosis.
• Social support: Addressing social needs like education, employment, and housing.
Individuals with a history of psychosis are more likely to struggle with substance abuse issues or alcohol misuse.
• Around 3% of the population in the United States will experience at least one episode of psychosis during their lifetime. Annually, around 100,000 teenagers and young adults in the United States will encounter their inaugural episode of psychosis.

Thelansis’s “Psychosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Psychosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Psychosis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Psychosis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Psychosis – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033